CNS Neuroscience & Therapeutics
Academic journal
| Discipline | Neurology |
|---|---|
| Language | English |
| Edited by | Mark H. Pollack, Roger Bullock |
| Publication details | |
Former name(s) | CNS Drug Reviews |
| History | 1995–present |
| Publisher | Wiley-Blackwell |
| Frequency | Bimonthly |
Impact factor | 7.035 (2021) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | CNS Neurosci. Ther. |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| ISSN | 1755-5930 (print) 1755-5949 (web) |
| LCCN | 2008243471 |
| OCLC no. | 221972947 |
| Links | |
| |
CNS Neuroscience & Therapeutics is a bimonthly peer-reviewed medical journal established in 1995 as CNS Drug Reviews and obtained its current title in 2008. It is published by Wiley-Blackwell and addresses topics in neurology and central nervous system therapeutic pharmacology.
External links
- Official website
- v
- t
- e
  | This article about a neurology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
- v
- t
- e
